
Following the recent launch of Deutsche Post DHL’s Strategy 2015, DHL, the world’s leading logistics company, today announced an enhanced strategy for providing superior levels of service and quality to customers in the Life Sciences and Healthcare sector. The announcement was made at the company’s 9th Annual Life Sciences and Healthcare Global Conference in Miami, USA, where it is hosting many of the world’s leading pharmaceutical, medical device and biotechnology companies.
“Strategy 2015 aims to broaden DHL’s leadership in the logistics sector by strengthening its cross-divisional collaboration in order to provide simplified and sustainable customer solutions, and identifies the growing Life Sciences and Healthcare industry as a key focus sector,” said Hermann Ude, CEO of DHL Global Forwarding and Freight, and DHL’s board member sponsor of the sector. “Because of the unique safety and regulatory requirements faced by the Life Sciences and Healthcare industry, its transportation and logistics needs require particularly rigorous levels of quality and competence in product handling. At the same time, the industry is increasingly turning to strategic partners for innovative solutions in order to support supply chain operations”, he concluded.
Our Life Science strategy includes: Competence Centers around the world with more focus on emerging markets to provide improved quality, compliance and visibility when moving products from manufacturer to end customer; GMP (Good Manufacturing Practice) and GDP (Good Distribution Practice) certified Regional Hubs - in Panama, Istanbul, Dubai, and Singapore - for warehousing and regional distribution of pharmaceutical products; a very active six sigma improvement process under the name ‘First Choice’; a global network of warehouse and transportation solutions for Clinical Trials; pan-European less-than-truckload temperature-controlled (LTL) Cold Chain road freight capabilities.
Building on its experience, network and infrastructure, the most recent enhancements to DHL’s Life Sciences and Healthcare strategy announced today include three key components:
“The enhanced strategy announced today reinforces DHL’s leadership position in Life Sciences and Healthcare logistics,” said Angelos Orfanos, President of Life Sciences and Healthcare of DHL Global Customer Solutions. “That strategy, combined with DHL’s global footprint and capabilities, high degree of competence, dedicated teams and infrastructure and customized industry processes, strongly positions DHL to continue to grow with the sector and drive its globalization with our customers.”
DHL Global Customer Solutions
Li Li Koh
Tel: +65 6879 8230
Email: lili.koh@dhl.com
Waggener Edstrom Worldwide for DHL Global Customer Solutions
Joe Roualdes
Tel: 415 823 2136
Email: jroualdes@waggeneredstrom.com
Global Customer Solutions (GCS) is DHL’s dedicated customer relationship management organization for the group’s top 100 customers worldwide. Established in 2004, GCS serves customers in all geographical regions, covering key industry sectors including Automotive, Aerospace, Consumer Products & Services, Engineering & Manufacturing, Life Sciences & Healthcare, and Technology. With 600 employees worldwide, GCS acts as an empowered single point of contact where the team designs and deploys tailored logistics solutions ranging from express, air, ocean, freight and contract logistics.
DHL – The Logistics company for the world
DHL is the global market leader in the logistics industry and “The Logistics company for the world”. DHL commits its expertise in international express, air and ocean freight, road and rail transportation, contract logistics and international mail services. A global network composed of more than 220 countries and territories and 310,000 employees worldwide offers customers superior service quality and local knowledge to satisfy their supply chain requirements. DHL accepts its social responsibility by supporting climate protection, disaster management and education.
DHL is part of Deutsche Post DHL. The Group generated revenue of more than 54 billion euros in 2008.